Genmab AS (GMAB) — Cash Flow Quality Index
Genmab AS (GMAB) has a Cash Flow Quality Index of 9.72x as of December 2025. Operating cash flow of $300.34 Million exceeds net income of $30.91 Million, indicating high earnings quality where cash backs reported profits. Explore Genmab AS cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Genmab AS Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Genmab AS across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Genmab AS to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Genmab AS (2013–2025)
Year-by-year earnings quality comparison for Genmab AS. For live market cap and the full company financial profile, see Genmab AS market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | $1.19 Billion | $963.76 Million | ▲ +24.3% |
| 2024 | 0.99x | $7.77 Billion | $7.84 Billion | ▼ -24.3% |
| 2023 | 1.31x | $7.38 Billion | $5.64 Billion | ▲ +135.4% |
| 2022 | 0.56x | $3.91 Billion | $7.04 Billion | ▼ -0.6% |
| 2021 | 0.56x | $2.23 Billion | $3.98 Billion | ▼ -58.6% |
| 2020 | 1.35x | $6.43 Billion | $4.76 Billion | ▲ +191.5% |
| 2019 | 0.46x | $1.33 Billion | $2.86 Billion | ▼ -26.3% |
| 2018 | 0.63x | $1.01 Billion | $1.61 Billion | ▼ -57.9% |
| 2017 | 1.49x | $1.59 Billion | $1.06 Billion | ▲ +415.2% |
| 2016 | 0.29x | $327.72 Million | $1.13 Billion | ▼ -29.5% |
| 2015 | 0.41x | $311.45 Million | $757.53 Million | ▼ -7.9% |
| 2014 | 0.45x | $132.67 Million | $297.35 Million | ▲ +137.5% |
| 2013 | -1.19x | $-128.00 Million | $107.64 Million | — |